Overview
Columbia University is the only major medical school in New York City designated by NCI as a Comprehensive Cancer Center. Patients benefit from the Cancer Center's alliance with Columbia, a time-honored Ivy League school with access to extensive basic science research and a highly respected Public School of Health. Our physicians are members of the Gynecologic Oncology Group (GOG), a multi-institutional clinical research group funded by the National Cancer Institute. This association gives our patients access to clinical trials involving the latest, most promising chemotherapeutics for women with gynecologic malignancies which may otherwise be unavailable. Clinical research and basic science research are two major focuses in the Division. Uterine and cervical cancer outcomes are improving year by year, thanks to improved detection technologies that facilitate early diagnosis and treatment of cancer. Research has increased the medical community's understanding of gynecologic cancer and has led to new medications and treatments. Our highly experienced gynecologic oncologists deliver and coordinate all aspects of patients' care from screening and consultation to the most difficult invasive surgeries through radiation and chemotherapy and follow-up care. The Center houses diagnostic instruments, facilities for minor procedures and consultation rooms in a single area for patients' comfort and convenience.
Types of Patients We Care for
Thomas Herzog, MD |
|
The Division of Gynecologic Oncology at the New York-Presbyterian Hospital's Herbert Irving Comprehensive Cancer Center provides a comprehensive program combining the most advanced, state-of-the-art diagnosis and treatment for women with gynecologic cancer with a personal touch between physician and patient.
